[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 49, "title": "Co-Founder, CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 570781, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Callahan CPA", "age": 53, "title": "Senior VP, CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 358981, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 367467, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 66, "title": "Co-Founder, Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 60, "title": "Co-Founder, Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.15, "open": 4.2, "dayLow": 4.0402, "dayHigh": 4.2699, "regularMarketPreviousClose": 4.15, "regularMarketOpen": 4.2, "regularMarketDayLow": 4.0402, "regularMarketDayHigh": 4.2699, "payoutRatio": 0.0, "beta": -0.883, "forwardPE": -0.58002734, "volume": 60953, "regularMarketVolume": 60953, "averageVolume": 100562, "averageVolume10days": 89260, "averageDailyVolume10Day": 89260, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 15466078, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 20.83, "fiftyDayAverage": 4.0583, "twoHundredDayAverage": 4.758445, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 8865774, "profitMargins": 0.0, "floatShares": 3759280, "sharesOutstanding": 3647660, "sharesShort": 140973, "sharesShortPriorMonth": 119203, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.038599998, "heldPercentInsiders": 0.02702, "heldPercentInstitutions": 0.02407, "shortRatio": 1.64, "shortPercentOfFloat": 0.0398, "impliedSharesOutstanding": 3647660, "bookValue": 2.191, "priceToBook": 1.9351894, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15545737, "trailingEps": -10.2, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": -0.591, "52WeekChange": -0.6012039, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 4.24, "targetHighPrice": 62.0, "targetLowPrice": 8.0, "targetMeanPrice": 25.5, "targetMedianPrice": 16.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 4, "totalCash": 12211321, "totalCashPerShare": 3.24, "ebitda": -14991883, "totalDebt": 5099079, "quickRatio": 2.462, "currentRatio": 2.546, "debtToEquity": 68.393, "returnOnAssets": -1.06539, "returnOnEquity": -53.05024, "grossProfits": -9445265, "freeCashflow": -12844647, "operatingCashflow": -18451388, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CING", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 2.16867, "regularMarketPrice": 4.24, "postMarketChangePercent": -0.235843, "postMarketPrice": 4.23, "postMarketChange": -0.00999975, "regularMarketChange": 0.0899997, "regularMarketDayRange": "4.0402 - 4.2699", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638973800000, "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 100562, "fiftyTwoWeekLowChange": 2.4399998, "fiftyTwoWeekLowChangePercent": 1.3555555, "fiftyTwoWeekRange": "1.8 - 20.83", "fiftyTwoWeekHighChange": -16.59, "fiftyTwoWeekHighChangePercent": -0.79644746, "fiftyTwoWeekChangePercent": -60.12039, "epsTrailingTwelveMonths": -10.2, "epsForward": -7.31, "epsCurrentYear": -2.89667, "priceEpsCurrentYear": -1.4637496, "fiftyDayAverageChange": 0.18169975, "fiftyDayAverageChangePercent": 0.04477238, "twoHundredDayAverageChange": -0.518445, "twoHundredDayAverageChangePercent": -0.10895262, "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-08", "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1744932816, "regularMarketTime": 1744920000, "exchange": "NCM", "messageBoardId": "finmb_1674914781", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Cingulate", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]